世界の濾胞性菌状息肉腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Folliculotropic Mycosis Fungoides Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4234
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、108ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、濾胞性菌状息肉腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（小分子、生物製剤）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・濾胞性菌状息肉腫治療の市場動向
・企業の競争状況、市場シェア
・濾胞性菌状息肉腫治療の種類別市場規模と予測2016-2027（小分子、生物製剤）
・濾胞性菌状息肉腫治療の用途別市場規模と予測2016-2027（病院、専門クリニック、その他）
・濾胞性菌状息肉腫治療の北米市場規模2016-2027（アメリカ、カナダ）
・濾胞性菌状息肉腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・濾胞性菌状息肉腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・濾胞性菌状息肉腫治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・濾胞性菌状息肉腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Takeda Pharmaceutical Company、Merck、Seattle Genetics、Kyowa Kirin、Eisai、Helsinn Healthcare、Horizon Therapeutics、Celegene Corporation、Azurity Pharmaceuticals、Elorac、Soligenix、Actelion Pharmaceuticals）
・結論

Market Analysis and Insights: Global Folliculotropic Mycosis Fungoides Treatment Market
The global Folliculotropic Mycosis Fungoides Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Folliculotropic Mycosis Fungoides Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Folliculotropic Mycosis Fungoides Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Folliculotropic Mycosis Fungoides Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Folliculotropic Mycosis Fungoides Treatment market.

Global Folliculotropic Mycosis Fungoides Treatment Scope and Market Size
Folliculotropic Mycosis Fungoides Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Folliculotropic Mycosis Fungoides Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Small Molecule
Biologics

Segment by Application
Hospital
Specialty Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Takeda Pharmaceutical Company
Merck
Seattle Genetics
Kyowa Kirin
Eisai
Helsinn Healthcare
Horizon Therapeutics
Celegene Corporation
Azurity Pharmaceuticals
Elorac
Soligenix
Actelion Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Folliculotropic Mycosis Fungoides Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Small Molecule
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global Folliculotropic Mycosis Fungoides Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Folliculotropic Mycosis Fungoides Treatment Market Perspective (2016-2027)
2.2 Folliculotropic Mycosis Fungoides Treatment Growth Trends by Regions
2.2.1 Folliculotropic Mycosis Fungoides Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Folliculotropic Mycosis Fungoides Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Folliculotropic Mycosis Fungoides Treatment Industry Dynamic
2.3.1 Folliculotropic Mycosis Fungoides Treatment Market Trends
2.3.2 Folliculotropic Mycosis Fungoides Treatment Market Drivers
2.3.3 Folliculotropic Mycosis Fungoides Treatment Market Challenges
2.3.4 Folliculotropic Mycosis Fungoides Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Folliculotropic Mycosis Fungoides Treatment Players by Revenue
3.1.1 Global Top Folliculotropic Mycosis Fungoides Treatment Players by Revenue (2016-2021)
3.1.2 Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Folliculotropic Mycosis Fungoides Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Folliculotropic Mycosis Fungoides Treatment Revenue
3.4 Global Folliculotropic Mycosis Fungoides Treatment Market Concentration Ratio
3.4.1 Global Folliculotropic Mycosis Fungoides Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Folliculotropic Mycosis Fungoides Treatment Revenue in 2020
3.5 Folliculotropic Mycosis Fungoides Treatment Key Players Head office and Area Served
3.6 Key Players Folliculotropic Mycosis Fungoides Treatment Product Solution and Service
3.7 Date of Enter into Folliculotropic Mycosis Fungoides Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Folliculotropic Mycosis Fungoides Treatment Breakdown Data by Type
4.1 Global Folliculotropic Mycosis Fungoides Treatment Historic Market Size by Type (2016-2021)
4.2 Global Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size by Type (2022-2027)

5 Folliculotropic Mycosis Fungoides Treatment Breakdown Data by Application
5.1 Global Folliculotropic Mycosis Fungoides Treatment Historic Market Size by Application (2016-2021)
5.2 Global Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Folliculotropic Mycosis Fungoides Treatment Market Size (2016-2027)
6.2 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Type
6.2.1 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2021)
6.2.2 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2022-2027)
6.2.3 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2027)
6.3 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Application
6.3.1 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2021)
6.3.2 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2022-2027)
6.3.3 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2027)
6.4 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Country
6.4.1 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2016-2021)
6.4.2 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Folliculotropic Mycosis Fungoides Treatment Market Size (2016-2027)
7.2 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Type
7.2.1 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2021)
7.2.2 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2022-2027)
7.2.3 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2027)
7.3 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Application
7.3.1 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2021)
7.3.2 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2022-2027)
7.3.3 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2027)
7.4 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Country
7.4.1 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2016-2021)
7.4.2 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size (2016-2027)
8.2 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Type
8.2.1 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Application
8.3.1 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Region
8.4.1 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size (2016-2027)
9.2 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Type
9.2.1 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2027)
9.3 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Application
9.3.1 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2027)
9.4 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Country
9.4.1 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size (2016-2027)
10.2 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Type
10.2.1 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Application
10.3.1 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Country
10.4.1 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Takeda Pharmaceutical Company
11.1.1 Takeda Pharmaceutical Company Company Details
11.1.2 Takeda Pharmaceutical Company Business Overview
11.1.3 Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Introduction
11.1.4 Takeda Pharmaceutical Company Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
11.1.5 Takeda Pharmaceutical Company Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Folliculotropic Mycosis Fungoides Treatment Introduction
11.2.4 Merck Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Seattle Genetics
11.3.1 Seattle Genetics Company Details
11.3.2 Seattle Genetics Business Overview
11.3.3 Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Introduction
11.3.4 Seattle Genetics Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
11.3.5 Seattle Genetics Recent Development
11.4 Kyowa Kirin
11.4.1 Kyowa Kirin Company Details
11.4.2 Kyowa Kirin Business Overview
11.4.3 Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Introduction
11.4.4 Kyowa Kirin Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
11.4.5 Kyowa Kirin Recent Development
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Eisai Business Overview
11.5.3 Eisai Folliculotropic Mycosis Fungoides Treatment Introduction
11.5.4 Eisai Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
11.5.5 Eisai Recent Development
11.6 Helsinn Healthcare
11.6.1 Helsinn Healthcare Company Details
11.6.2 Helsinn Healthcare Business Overview
11.6.3 Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Introduction
11.6.4 Helsinn Healthcare Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
11.6.5 Helsinn Healthcare Recent Development
11.7 Horizon Therapeutics
11.7.1 Horizon Therapeutics Company Details
11.7.2 Horizon Therapeutics Business Overview
11.7.3 Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Introduction
11.7.4 Horizon Therapeutics Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
11.7.5 Horizon Therapeutics Recent Development
11.8 Celegene Corporation
11.8.1 Celegene Corporation Company Details
11.8.2 Celegene Corporation Business Overview
11.8.3 Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Introduction
11.8.4 Celegene Corporation Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
11.8.5 Celegene Corporation Recent Development
11.9 Azurity Pharmaceuticals
11.9.1 Azurity Pharmaceuticals Company Details
11.9.2 Azurity Pharmaceuticals Business Overview
11.9.3 Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Introduction
11.9.4 Azurity Pharmaceuticals Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
11.9.5 Azurity Pharmaceuticals Recent Development
11.10 Elorac
11.10.1 Elorac Company Details
11.10.2 Elorac Business Overview
11.10.3 Elorac Folliculotropic Mycosis Fungoides Treatment Introduction
11.10.4 Elorac Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
11.10.5 Elorac Recent Development
11.11 Soligenix
11.11.1 Soligenix Company Details
11.11.2 Soligenix Business Overview
11.11.3 Soligenix Folliculotropic Mycosis Fungoides Treatment Introduction
11.11.4 Soligenix Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
11.11.5 Soligenix Recent Development
11.12 Actelion Pharmaceuticals
11.12.1 Actelion Pharmaceuticals Company Details
11.12.2 Actelion Pharmaceuticals Business Overview
11.12.3 Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Introduction
11.12.4 Actelion Pharmaceuticals Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
11.12.5 Actelion Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Folliculotropic Mycosis Fungoides Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Small Molecule
Table 3. Key Players of Biologics
Table 4. Global Folliculotropic Mycosis Fungoides Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Folliculotropic Mycosis Fungoides Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Folliculotropic Mycosis Fungoides Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Folliculotropic Mycosis Fungoides Treatment Market Share by Regions (2016-2021)
Table 8. Global Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Folliculotropic Mycosis Fungoides Treatment Market Share by Regions (2022-2027)
Table 10. Folliculotropic Mycosis Fungoides Treatment Market Trends
Table 11. Folliculotropic Mycosis Fungoides Treatment Market Drivers
Table 12. Folliculotropic Mycosis Fungoides Treatment Market Challenges
Table 13. Folliculotropic Mycosis Fungoides Treatment Market Restraints
Table 14. Global Folliculotropic Mycosis Fungoides Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Folliculotropic Mycosis Fungoides Treatment Market Share by Players (2016-2021)
Table 16. Global Top Folliculotropic Mycosis Fungoides Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Folliculotropic Mycosis Fungoides Treatment as of 2020)
Table 17. Ranking of Global Top Folliculotropic Mycosis Fungoides Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Folliculotropic Mycosis Fungoides Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Folliculotropic Mycosis Fungoides Treatment Product Solution and Service
Table 21. Date of Enter into Folliculotropic Mycosis Fungoides Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Folliculotropic Mycosis Fungoides Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Takeda Pharmaceutical Company Company Details
Table 62. Takeda Pharmaceutical Company Business Overview
Table 63. Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Product
Table 64. Takeda Pharmaceutical Company Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021) & (US$ Million)
Table 65. Takeda Pharmaceutical Company Recent Development
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Folliculotropic Mycosis Fungoides Treatment Product
Table 69. Merck Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Seattle Genetics Company Details
Table 72. Seattle Genetics Business Overview
Table 73. Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Product
Table 74. Seattle Genetics Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021) & (US$ Million)
Table 75. Seattle Genetics Recent Development
Table 76. Kyowa Kirin Company Details
Table 77. Kyowa Kirin Business Overview
Table 78. Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Product
Table 79. Kyowa Kirin Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021) & (US$ Million)
Table 80. Kyowa Kirin Recent Development
Table 81. Eisai Company Details
Table 82. Eisai Business Overview
Table 83. Eisai Folliculotropic Mycosis Fungoides Treatment Product
Table 84. Eisai Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021) & (US$ Million)
Table 85. Eisai Recent Development
Table 86. Helsinn Healthcare Company Details
Table 87. Helsinn Healthcare Business Overview
Table 88. Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Product
Table 89. Helsinn Healthcare Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021) & (US$ Million)
Table 90. Helsinn Healthcare Recent Development
Table 91. Horizon Therapeutics Company Details
Table 92. Horizon Therapeutics Business Overview
Table 93. Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Product
Table 94. Horizon Therapeutics Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021) & (US$ Million)
Table 95. Horizon Therapeutics Recent Development
Table 96. Celegene Corporation Company Details
Table 97. Celegene Corporation Business Overview
Table 98. Celegene Corporation Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021) & (US$ Million)
Table 99. Celegene Corporation Recent Development
Table 100. Azurity Pharmaceuticals Company Details
Table 101. Azurity Pharmaceuticals Business Overview
Table 102. Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Product
Table 103. Azurity Pharmaceuticals Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021) & (US$ Million)
Table 104. Azurity Pharmaceuticals Recent Development
Table 105. Elorac Company Details
Table 106. Elorac Business Overview
Table 107. Elorac Folliculotropic Mycosis Fungoides Treatment Product
Table 108. Elorac Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021) & (US$ Million)
Table 109. Elorac Recent Development
Table 110. Soligenix Company Details
Table 111. Soligenix Business Overview
Table 112. Soligenix Folliculotropic Mycosis Fungoides Treatment Product
Table 113. Soligenix Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021) & (US$ Million)
Table 114. Soligenix Recent Development
Table 115. Actelion Pharmaceuticals Company Details
Table 116. Actelion Pharmaceuticals Business Overview
Table 117. Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Product
Table 118. Actelion Pharmaceuticals Revenue in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021) & (US$ Million)
Table 119. Actelion Pharmaceuticals Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Folliculotropic Mycosis Fungoides Treatment Market Share by Type: 2020 VS 2027
Figure 2. Small Molecule Features
Figure 3. Biologics Features
Figure 4. Global Folliculotropic Mycosis Fungoides Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Specialty Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Folliculotropic Mycosis Fungoides Treatment Report Years Considered
Figure 9. Global Folliculotropic Mycosis Fungoides Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Folliculotropic Mycosis Fungoides Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Folliculotropic Mycosis Fungoides Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Folliculotropic Mycosis Fungoides Treatment Market Share by Regions (2022-2027)
Figure 13. Global Folliculotropic Mycosis Fungoides Treatment Market Share by Players in 2020
Figure 14. Global Top Folliculotropic Mycosis Fungoides Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Folliculotropic Mycosis Fungoides Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Folliculotropic Mycosis Fungoides Treatment Revenue in 2020
Figure 16. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Folliculotropic Mycosis Fungoides Treatment Market Share by Type (2016-2027)
Figure 20. North America Folliculotropic Mycosis Fungoides Treatment Market Share by Application (2016-2027)
Figure 21. North America Folliculotropic Mycosis Fungoides Treatment Market Share by Country (2016-2027)
Figure 22. United States Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Folliculotropic Mycosis Fungoides Treatment Market Share by Type (2016-2027)
Figure 26. Europe Folliculotropic Mycosis Fungoides Treatment Market Share by Application (2016-2027)
Figure 27. Europe Folliculotropic Mycosis Fungoides Treatment Market Share by Country (2016-2027)
Figure 28. Germany Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Share by Region (2016-2027)
Figure 38. China Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Folliculotropic Mycosis Fungoides Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Folliculotropic Mycosis Fungoides Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Folliculotropic Mycosis Fungoides Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Folliculotropic Mycosis Fungoides Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Takeda Pharmaceutical Company Revenue Growth Rate in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
Figure 58. Merck Revenue Growth Rate in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
Figure 59. Seattle Genetics Revenue Growth Rate in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
Figure 60. Kyowa Kirin Revenue Growth Rate in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
Figure 61. Eisai Revenue Growth Rate in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
Figure 62. Helsinn Healthcare Revenue Growth Rate in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
Figure 63. Horizon Therapeutics Revenue Growth Rate in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
Figure 64. Celegene Corporation Revenue Growth Rate in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
Figure 65. Azurity Pharmaceuticals Revenue Growth Rate in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
Figure 66. Elorac Revenue Growth Rate in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
Figure 67. Soligenix Revenue Growth Rate in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
Figure 68. Actelion Pharmaceuticals Revenue Growth Rate in Folliculotropic Mycosis Fungoides Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の色汗症治療市場規模・現状・予測（2021年-2027年）

Global Chromhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5658 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、色汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アポクリン色汗症、エクリン色汗症、偽色汗症）、用途別市場規模（病院＆診療所、専門医＆皮膚科医院、その他）、主要地域別市場規模（北米、アメリカ、...

世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年）

Global Choledocholithiasis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4004 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、総胆管結石症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科的治療）、用途別市場規模（病院、専門クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界の痙性斜頸治療市場規模・現状・予測（2021年-2027年）

Global Cervical Dystonia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5653 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、痙性斜頸治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス菌、抗コリン作用薬、ドーパミン作動薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（...

世界のアルギニン血症治療市場規模・現状・予測（2021年-2027年）

Global Argininemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3852 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アルギニン血症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の多汗症治療市場規模・現状・予測（2021年-2027年）

Global Hyperhidrosis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4337 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、多汗症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、外科治療、理学療法、その他）、用途別市場規模（病院、皮膚科、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の線維形成性小円形細胞腫瘍治療市場規模・現状・予測（2021年-2027年） Desmoplastic Small Round Cell Tumor (DSRCT) refers to a rare kind of aggressive soft tissue cancer that usually begins at abdomen and hematogenously disseminates to the liver. Market Analysis and Insights: Global Desmoplastic Small Round Cell Tumor Treatment Market The global Desmoplastic Small Roun…
世界の非薬物式うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Free Depression Treatment Market The global Drug Free Depression Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…
世界のグルテン不耐性治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gluten Intolerance Treatment Market The global Gluten Intolerance Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
世界の総胆管結石症治療市場規模・現状・予測（2021年-2027年） Choledocholithiasis is a condition wherein gall stones are found in the common bile duct instead of the gall bladder. Market Analysis and Insights: Global Choledocholithiasis Treatment Market The global Choledocholithiasis Treatment market size is projected to reach US$ XX million by 2027, from US$ …
世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Wilms' Tumor Treatment Market The global Wilms' Tumor Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…